Loading
companiesCompany
Miltenyi Biotec
Miltenyi Biotec, a private German company, makes the CliniMACS Prodigy, a closed automated device that manufactures CAR-T cells at the point of care, plus the magnetic cell separation and lentiviral vectors behind it, and its own CD20/CD19 bispecific CAR-T is in late-stage lymphoma trials.
Overview
Private German company supplying magnetic cell separation (CliniMACS), closed automated manufacturing (Prodigy), lentiviral vectors, and its own CAR-T candidates (zamtocabtagene autoleucel, MB-CART2019.1, a CD20/CD19 bispecific CAR-T in late-stage trials for lymphoma). A backbone of point-of-care cell manufacturing in Europe and Asia.
Headquarters
Bergisch Gladbach, DE
Manufacturing
Capacity map- Miltenyi Biotec Bergisch Gladbach, DECell therapy, Viral vector
Type
Website
Similar pages
- CompanyCellares
Shares Closed automated cell-therapy manufacturing, Point-of-care and decentralised cell manufacturing, Autologous CAR-T manufacturing, batch by batch and the tag supporting.
- CompanyCytiva (Danaher)
Shares Closed automated cell-therapy manufacturing, Autologous CAR-T manufacturing, batch by batch and the tag supporting.
- CompanyTerumo Blood and Cell Technologies
Shares Closed automated cell-therapy manufacturing and the tag supporting.
- CompanyGalapagos
Shares Point-of-care and decentralised cell manufacturing and the tag supporting.
- TechnologyCell-therapy orchestration and chain-of-identity software
Shares Autologous CAR-T manufacturing, batch by batch and the tag supporting.
- TechnologyCell-therapy release and potency testing
Shares Closed automated cell-therapy manufacturing, Autologous CAR-T manufacturing, batch by batch and the tag supporting.
- CompanyLonza
Shares Closed automated cell-therapy manufacturing, Autologous CAR-T manufacturing, batch by batch and the tag supporting.
- TechnologyApheresis and starting-material collection
Shares Autologous CAR-T manufacturing, batch by batch and the tag supporting.